iTeos Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
iTeos Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q2 2024.
  • iTeos Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 39.7M shares, a 11% increase year-over-year.
  • iTeos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 35.8M shares, a 0.6% increase from 2022.
  • iTeos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 35.6M shares, a 1.05% increase from 2021.
  • iTeos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 35.2M shares, a 133% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 39.7M +3.93M +11% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 35.8M +127K +0.36% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 35.8M +211K +0.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 35.8M +208K +0.58% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 35.8M +222K +0.63% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 35.7M +223K +0.63% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 35.6M +371K +1.05% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 35.6M +378K +1.08% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 35.5M +427K +1.22% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 35.5M +407K +1.16% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 35.2M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 35.2M +10.8M +44.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 35.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 35.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 24.3M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.